National Immunization Survey-Teen (NIS-Teen) 2019, Texas

Source: CDC NIS-Teen Report

About the National Immunization Survey-Teen (NIS-Teen)

The NIS-Teen is a national survey conducted every year by the CDC to assess vaccination coverage levels, or the percentage of people vaccinated, among adolescents 13-17 years of age. This study collects data by interviewing households in all 50 states, the District of Columbia, and smaller selected areas. The interviews are conducted by telephone, with households selected at random. To ensure the accuracy of the vaccination coverage estimates, the interview is followed by collection of vaccination records from healthcare providers by mail. The parents and guardians of eligible teens are asked during the telephone interview for consent to contact the adolescents’ vaccination providers to verify their records.

The NIS-Teen was established to provide an on-going, consistent data set for analyzing vaccination coverage levels among adolescents in the United States and to share this information with interested public health partners. The NIS-Teen provides national and statewide estimates of vaccination coverage, including new vaccines as they are licensed and recommended for use. It also helps track progress towards the Healthy People 2020 goals.

Stay-at-home orders due to COVID-19 in March 2020 may have had a minor effect on the processing of some provider-reported data from late in the survey year, but this did not significantly affect the demographics of children or vaccination coverage estimates.

Survey Sample

The survey assessed the vaccination histories of approximately 20,000 adolescents aged 13-17 years in the U.S. These adolescents were born between January 2001 and February 2007. In addition to Texas overall, rates are also available for four local areas – City of Houston, El Paso County, Dallas County, and Bexar County.

Vaccines Included

The following vaccine doses routinely recommended starting at 11-12 years of age were measured in the 2019 NIS-Teen:

  • ≥1 Tetanus-diphtheria-pertussis (Tdap) vaccine
  • ≥1 dose of Quadrivalent Meningococcal Conjugate (MenACWY) vaccine
  • ≥1 dose of human papillomavirus (HPV) vaccine
  • HPV vaccine, Up-to-Date, either two or three doses dependent on age of initiation

Vaccination Coverage Levels

 NIS-Teen Immunization Coverage Estimates in the U.S and Texas, 2018-2019        
VaccineU.S. National Average 2019Texas 2018Texas 2019

2018 to 2019 Texas Percentage Point Change (+/-)

HPV vaccine, ≥1 dose71.5%   59.9%   65.1%   +5.2%   
HPV vaccine, Up-To-Date54.2%   43.5%   48.4%   +4.9%   
MenACWY, ≥1 dose88.9%   86.7%   85.9%   -0.8%   
Tdap, ≥1 dose90.2%   83.4%84.8%   +1.4%   


NIS-Teen Immunization Coverage Estimates for Tdap and MenACWY by Jurisdiction, 2019, bar graph

See accessible data table of chart below:

 NIS-Teen Immunization Coverage Estimates for Tdap and MenACWY by Jurisdiction, 2019            
VaccineUSTexas City of Houston Dallas County El Paso County Bexar County 
≥1 Tdap90.2%84.8%91.8%84.6%89.1%83.3%
≥1 MenACWY88.9%85.9%92.0%86.6%93.5%87.4%


NIS-Teen COverage Estimates, for HPV by Gender and Jurisdiction, 2019 Bar Graph      

See accessible data table of chart below:

 NIS-Teen Immunization Coverage Estimates for HPV by Gender and Jurisdiction, 2019             
VaccineUSTexas City of Houston Dallas County El Paso County Bexar County 
≥1 HPV, females73.2% 64.2%84.2%68.5%85.4%65.7%
HPV UTD, females56.8% 50.6%61.6%52.7%71.4%47.7% 
≥1 HPV, males69.8%65.9%75.8%67.6%82.3%68.8%
HPV UTD, males51.8% 46.3% 54.2% 48.3% 56.3% 47.3% 

NIS Teen Immunization Coverage Estimates for One-Dose HPV by Gender, U.S. and Texas, 2010 - 2019     

The same methodology was not used for all years.

See accessible data table of chart below:

 NIS-Teen One-Dose HPV Immunization Coverage Estimates by Gender, U.S. and Texas, 2010-2019a                    
 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
United States, Female48.7%53.0%53.8%56.7%60.0%62.8%65.1%68.6%69.9% 73.2%
Texas, Female 47.5%48.8%51.2%55.5%50.7%60.1%54.5%60.4%64.6% 64.2%
United States, Male n/a8.3%20.8%33.6%41.7%49.8%56.0%62.6%66.3% 69.8%
Texas, Male n/a10.4%24.0%33.7%36.6%41.4%44.3%55.2%55.5% 65.9%

The same methodology was not used for all years.

Last updated November 16, 2021